메뉴 건너뛰기




Volumn 3, Issue 9, 2007, Pages 496-503

The assessment of ankylosing spondylitis in clinical practice

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

EID: 34548395104     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0591     Document Type: Review
Times cited : (45)

References (51)
  • 1
    • 0016296266 scopus 로고
    • Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome
    • Moll JM et al. (1974) Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine (Baltimore) 53: 343-364
    • (1974) Medicine (Baltimore) , vol.53 , pp. 343-364
    • Moll, J.M.1
  • 2
    • 0021272107 scopus 로고    scopus 로고
    • Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria
    • van der Linden S et al. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361-368
    • (1984) Arthritis Rheum , vol.27 , pp. 361-368
    • van der Linden, S.1
  • 3
    • 20444371964 scopus 로고    scopus 로고
    • Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis
    • Stone M et al. (2005) Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum 53: 445-451
    • (2005) Arthritis Rheum , vol.53 , pp. 445-451
    • Stone, M.1
  • 4
    • 0031757212 scopus 로고    scopus 로고
    • Quality of life in patients with ankylosing spondylitis
    • Ward MM (1998) Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 24: 815-827
    • (1998) Rheum Dis Clin North Am , vol.24 , pp. 815-827
    • Ward, M.M.1
  • 5
    • 0034020245 scopus 로고    scopus 로고
    • Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - results from the German rheumatological database. German Collaborative Arthritis Centers
    • Zink A et al. (2000) Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 27: 613-622
    • (2000) J Rheumatol , vol.27 , pp. 613-622
    • Zink, A.1
  • 6
    • 0032915527 scopus 로고    scopus 로고
    • Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis
    • Spoorenberg A et al. (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26: 980-984
    • (1999) J Rheumatol , vol.26 , pp. 980-984
    • Spoorenberg, A.1
  • 7
    • 0030697069 scopus 로고    scopus 로고
    • Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group
    • van der Heijde D et al. (1997) Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol 24: 2225-2229
    • (1997) J Rheumatol , vol.24 , pp. 2225-2229
    • van der Heijde, D.1
  • 8
    • 0029969624 scopus 로고    scopus 로고
    • The Bath Ankylosing Spondylitis Patient Global Score (BAS-G)
    • Jones SD et al. (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35: 66-71
    • (1996) Br J Rheumatol , vol.35 , pp. 66-71
    • Jones, S.D.1
  • 9
    • 0028579768 scopus 로고
    • A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index
    • Calin A et al. (1994) A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21: 2281-2285
    • (1994) J Rheumatol , vol.21 , pp. 2281-2285
    • Calin, A.1
  • 10
    • 0023851825 scopus 로고
    • Evaluation of a functional index and an articular index in ankylosing spondylitis
    • Dougados M et al. (1988) Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 15: 302-307
    • (1988) J Rheumatol , vol.15 , pp. 302-307
    • Dougados, M.1
  • 11
    • 33645124111 scopus 로고    scopus 로고
    • ASAS/EULAR recommendations for the management of ankylosing spondylitis
    • Zochling J et al. (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65: 442-452
    • (2006) Ann Rheum Dis , vol.65 , pp. 442-452
    • Zochling, J.1
  • 12
    • 0037783485 scopus 로고    scopus 로고
    • Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
    • Brandt J et al. (2003) Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 48: 1667-1675
    • (2003) Arthritis Rheum , vol.48 , pp. 1667-1675
    • Brandt, J.1
  • 13
    • 20444371964 scopus 로고    scopus 로고
    • Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis
    • Stone M et al. (2005) Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis. Arthritis Rheum 53: 445-451
    • (2005) Arthritis Rheum , vol.53 , pp. 445-451
    • Stone, M.1
  • 14
    • 24944507178 scopus 로고    scopus 로고
    • Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept
    • Davis JC, Jr et al. (2005) Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept. J Rheumatol 32: 1751-1754
    • (2005) J Rheumatol , vol.32 , pp. 1751-1754
    • Davis Jr, J.C.1
  • 15
    • 0028575453 scopus 로고
    • A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index
    • Garrett S et al. (1994) A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21: 2286-2291
    • (1994) J Rheumatol , vol.21 , pp. 2286-2291
    • Garrett, S.1
  • 16
    • 0032722934 scopus 로고    scopus 로고
    • Defining disease activity in ankylosing spondylitis: Is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?
    • Calin A et al. (1999) Defining disease activity in ankylosing spondylitis: Is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 38: 878-882
    • (1999) Rheumatology (Oxford) , vol.38 , pp. 878-882
    • Calin, A.1
  • 17
    • 1842680781 scopus 로고    scopus 로고
    • Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis
    • Yildirim K et al. (2004) Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis. South Med J 97: 350-353
    • (2004) South Med J , vol.97 , pp. 350-353
    • Yildirim, K.1
  • 18
    • 0032914045 scopus 로고    scopus 로고
    • Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: A literature review
    • Ruof J and Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: A literature review. J Rheumatol 26: 966-970
    • (1999) J Rheumatol , vol.26 , pp. 966-970
    • Ruof, J.1    Stucki, G.2
  • 19
    • 0022448738 scopus 로고
    • Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis
    • Sheehan NJ et al. (1986) Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 25: 171-174
    • (1986) Br J Rheumatol , vol.25 , pp. 171-174
    • Sheehan, N.J.1
  • 20
    • 34548404712 scopus 로고    scopus 로고
    • Lipid bioprofiles and correlation with disease activity measures in the spondyloarthropathies [abstract]
    • Molloy C et al. (2007) Lipid bioprofiles and correlation with disease activity measures in the spondyloarthropathies [abstract]. Ann Rheum Dis 66
    • (2007) Ann Rheum Dis , vol.66
    • Molloy, C.1
  • 21
    • 18344419026 scopus 로고    scopus 로고
    • Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: International experience
    • Iii51-iii60
    • Braun J et al. (2002) Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: International experience. Ann Rheum Dis 61 (Suppl 3): Iii51-iii60
    • (2002) Ann Rheum Dis , vol.61 , Issue.SUPPL. 3
    • Braun, J.1
  • 22
    • 2442666723 scopus 로고    scopus 로고
    • Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis
    • Rudwaleit M et al. (2004) Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63: 665-670
    • (2004) Ann Rheum Dis , vol.63 , pp. 665-670
    • Rudwaleit, M.1
  • 23
    • 0346690017 scopus 로고    scopus 로고
    • Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis
    • Stone MA et al. (2004) Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis. Ann Rheum Dis 63: 84-87
    • (2004) Ann Rheum Dis , vol.63 , pp. 84-87
    • Stone, M.A.1
  • 24
    • 14944375911 scopus 로고    scopus 로고
    • Cartilage biomarkers in ankylosing spondylitis: Relationship to clinical variables and treatment response
    • Kim TH et al. (2005) Cartilage biomarkers in ankylosing spondylitis: Relationship to clinical variables and treatment response. Arthritis Rheum 52: 885-891
    • (2005) Arthritis Rheum , vol.52 , pp. 885-891
    • Kim, T.H.1
  • 25
    • 10444279986 scopus 로고    scopus 로고
    • A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis
    • Robertson LP and Davis MJ (2004) A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology (Oxford) 43: 1565-1568
    • (2004) Rheumatology (Oxford) , vol.43 , pp. 1565-1568
    • Robertson, L.P.1    Davis, M.J.2
  • 26
    • 47849102135 scopus 로고    scopus 로고
    • Longitudinal Analyses of disease outcomes in Ankylosing Spondylitis yield insight into the natural history of AS [abstract]
    • Stone MA et al. (2007) Longitudinal Analyses of disease outcomes in Ankylosing Spondylitis yield insight into the natural history of AS [abstract]. Ann Rheum Dis 66
    • (2007) Ann Rheum Dis , vol.66
    • Stone, M.A.1
  • 27
    • 0028129277 scopus 로고
    • Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index
    • Jenkinson TR et al. (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21 1694-1698
    • (1994) J Rheumatol , vol.21 , pp. 1694-1698
    • Jenkinson, T.R.1
  • 28
    • 21344456394 scopus 로고    scopus 로고
    • Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: Can assessment of spinal mobility be a proxy for radiographic evaluation?
    • Wanders A et al. (2005) Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: Can assessment of spinal mobility be a proxy for radiographic evaluation? Ann Rheum Dis 64: 988-994
    • (2005) Ann Rheum Dis , vol.64 , pp. 988-994
    • Wanders, A.1
  • 29
    • 0029156646 scopus 로고
    • Ankylosing spondylitis: The correlation between a new metrology score and radiology
    • Kennedy LG et al. (1995) Ankylosing spondylitis: The correlation between a new metrology score and radiology. Br J Rheumatol 34 767-770
    • (1995) Br J Rheumatol , vol.34 , pp. 767-770
    • Kennedy, L.G.1
  • 30
    • 33749189105 scopus 로고    scopus 로고
    • The relationship between severity and extent of spinal involvement and spinal mobility and physical functioning in patients with ankylosing spondylitis
    • Kaya T et al. (2006) The relationship between severity and extent of spinal involvement and spinal mobility and physical functioning in patients with ankylosing spondylitis. Clin Rheumatol 25: 835-839
    • (2006) Clin Rheumatol , vol.25 , pp. 835-839
    • Kaya, T.1
  • 31
    • 33747888630 scopus 로고    scopus 로고
    • Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index
    • Maksymowych WP et al. (2006) Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index. Arthritis Rheum 55: 575-582
    • (2006) Arthritis Rheum , vol.55 , pp. 575-582
    • Maksymowych, W.P.1
  • 32
    • 34547468597 scopus 로고    scopus 로고
    • INSPIRE Lateral flexion: A new method to measure lateral spinal mobility in patients with spondyloarthritis [abstract]
    • Braun J (2006) INSPIRE Lateral flexion: A new method to measure lateral spinal mobility in patients with spondyloarthritis [abstract]. Arthritis Rheum 54: S476
    • (2006) Arthritis Rheum , vol.54
    • Braun, J.1
  • 33
    • 0037331654 scopus 로고    scopus 로고
    • Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: A cross-sectional study
    • D'Agostino MA et al. (2003) Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 48: 523-533
    • (2003) Arthritis Rheum , vol.48 , pp. 523-533
    • D'Agostino, M.A.1
  • 34
    • 33745894976 scopus 로고    scopus 로고
    • Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial
    • van der Heidje D et al. (2006) Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54: 2136-2146
    • (2006) Arthritis Rheum , vol.54 , pp. 2136-2146
    • van der Heidje, D.1
  • 35
    • 0036786842 scopus 로고    scopus 로고
    • Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy
    • Balint PV et al. (2002) Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 61: 905-910
    • (2002) Ann Rheum Dis , vol.61 , pp. 905-910
    • Balint, P.V.1
  • 36
    • 0023131042 scopus 로고
    • Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis
    • Mander M et al. (1987) Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46: 197-202
    • (1987) Ann Rheum Dis , vol.46 , pp. 197-202
    • Mander, M.1
  • 37
    • 0037307863 scopus 로고    scopus 로고
    • Assessment of enthesitis in ankylosing spondylitis
    • Heuft-Dorenbosch L et al. (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62: 127-132
    • (2003) Ann Rheum Dis , vol.62 , pp. 127-132
    • Heuft-Dorenbosch, L.1
  • 38
    • 0037029430 scopus 로고    scopus 로고
    • Treatment of active ankylosing spondylitis with infliximab: A randomised controlled multicentre trial
    • Braun J et al. (2002) Treatment of active ankylosing spondylitis with infliximab: A randomised controlled multicentre trial. Lancet 359: 1187-1193
    • (2002) Lancet , vol.359 , pp. 1187-1193
    • Braun, J.1
  • 39
    • 34548458540 scopus 로고    scopus 로고
    • Evaluating enthesitis in patients with spondyloarthritis (SpA) [abstract]
    • Gladman DD et al. (2006) Evaluating enthesitis in patients with spondyloarthritis (SpA) [abstract]. Arthritis Rheum 54
    • (2006) Arthritis Rheum , vol.54
    • Gladman, D.D.1
  • 40
    • 33645774396 scopus 로고    scopus 로고
    • Ultrasound detection of entheseal insertions in the foot of patients with spondyloarthropathy
    • Borman P et al. (2006) Ultrasound detection of entheseal insertions in the foot of patients with spondyloarthropathy. Clin Rheumatol 25: 373-377
    • (2006) Clin Rheumatol , vol.25 , pp. 373-377
    • Borman, P.1
  • 41
    • 0034888069 scopus 로고    scopus 로고
    • Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis
    • Anderson JJ et al. (2001) Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 44: 1876-1886
    • (2001) Arthritis Rheum , vol.44 , pp. 1876-1886
    • Anderson, J.J.1
  • 42
    • 0034881482 scopus 로고    scopus 로고
    • Response criteria and criteria for clinically important improvement: Separate and equal?
    • Ward MM (2001) Response criteria and criteria for clinically important improvement: Separate and equal? Arthritis Rheum 44: 1728-1729
    • (2001) Arthritis Rheum , vol.44 , pp. 1728-1729
    • Ward, M.M.1
  • 43
    • 7244260384 scopus 로고    scopus 로고
    • Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis
    • Brandt J et al. (2004) Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis. Ann Rheum Dis 63: 1438-1444
    • (2004) Ann Rheum Dis , vol.63 , pp. 1438-1444
    • Brandt, J.1
  • 44
    • 2642512444 scopus 로고    scopus 로고
    • Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics
    • Stone MA et al. (2004) Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics. Arthritis Rheum 51: 316-320
    • (2004) Arthritis Rheum , vol.51 , pp. 316-320
    • Stone, M.A.1
  • 45
    • 33846999309 scopus 로고    scopus 로고
    • Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis
    • Maksymowych WP et al. (2007) Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Arthritis Rheum 57: 133-139
    • (2007) Arthritis Rheum , vol.57 , pp. 133-139
    • Maksymowych, W.P.1
  • 46
    • 33845481626 scopus 로고    scopus 로고
    • Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis
    • Tubach F et al. (2006) Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis. Arthritis Rheum 55: 960-963
    • (2006) Arthritis Rheum , vol.55 , pp. 960-963
    • Tubach, F.1
  • 47
    • 22844439575 scopus 로고    scopus 로고
    • BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology
    • Keat A et al. (2005) BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology. Rheumatology (Oxford 44: 939-947
    • (2005) Rheumatology (Oxford , vol.44 , pp. 939-947
    • Keat, A.1
  • 48
    • 0038724286 scopus 로고    scopus 로고
    • Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis
    • Maksymowych WP et al. (2003) Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis. J Rheumatol 30 1356-1363
    • (2003) J Rheumatol , vol.30 , pp. 1356-1363
    • Maksymowych, W.P.1
  • 49
    • 0038423033 scopus 로고    scopus 로고
    • International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
    • Braun J et al. (2003) International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62: 817-824
    • (2003) Ann Rheum Dis , vol.62 , pp. 817-824
    • Braun, J.1
  • 50
    • 0021272107 scopus 로고    scopus 로고
    • van der Linden et al. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361-368
    • van der Linden et al. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361-368
  • 51
    • 0026003027 scopus 로고
    • The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
    • Dougados M et al. (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34: 1218-1227
    • (1991) Arthritis Rheum , vol.34 , pp. 1218-1227
    • Dougados, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.